FindTrial
Sign In

A single-center pancreatic ductal adenocarcinoma study based on multiomic integrative analysis

A single-center pancreatic ductal adenocarcinoma study based on multiomic integrative analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097983
Enrollment
Unknown
Registered
2025-02-28
Start date
2024-02-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Interventions

Pancreatic Adenocarcinoma:none

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1) Undergo surgical treatment in the Affiliated Cancer Hospital of Fudan University from January 2010 to August 2024; 2) Postoperative pathological confirmation of pancreatic ductal adenocarcinoma; 3) Have signed the informed consent form for the collection of tissue bank samples, agreeing to the use of their specimens and related clinical data for scientific research.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1) Combined with other malignant tumors; 2) Lack of clinical data.

Design outcomes

Primary

MeasureTime frame
Overall Survival;—

Countries

China

Contacts

Public ContactXianjun Yu

Fudan University Shanghai Cancer Center

yuxianjun@fudanpci.org+86 138 0166 9875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026